MANNKIND CORP Adjustments to Additional Paid in Capital, Warrant Issued
MANNKIND CORP (MNKD) reported Adjustments to Additional Paid in Capital, Warrant Issued of $12.75 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-27.
Discontinued › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2018-02-27
- MANNKIND CORP adjustments to additional paid in capital, warrant issued for the quarter ending 2012-09-30 was $7.60M.
- MANNKIND CORP adjustments to additional paid in capital, warrant issued for fiscal 2016 was $12.75M, a 6211.88% increase from fiscal 2015.
- MANNKIND CORP adjustments to additional paid in capital, warrant issued for fiscal 2015 was $202.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|
| 2016-12-31 | $12.75M 10-K · filed 2018-02-27 | ||
| 2015-12-31 | $202.00K 10-K · filed 2018-02-27 | -$202.00K 10-K · filed 2016-03-15 | |
| 2012-09-30 | $7.60M 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |